It has been reported that shifts in the fluorescence emission spectrum of the introduced tryptophans in the ␤F155W mutant of Escherichia coli F 1 (bovine heart mitochondria F 1 residue number) can quantitatively distinguish between the number of catalytic sites occupied with ADP and ATP during steady-state ATP hydrolysis (Weber, J., Bowman, C., and Senior, A. E. 
The F 0 F 1 -ATP synthases couple proton or sodium ion translocation to ATP synthesis and hydrolysis in energy-transducing membranes. They are composed of F 0 , an integral membrane protein complex that mediates proton translocation, and F 1 , a peripheral membrane protein complex that contains the catalytic sites. When separated from F 0 as a soluble complex, F 1 is an ATPase composed of five different subunits with ␣ 3 ␤ 3 ␥␦⑀ stoichiometry (1, 2) . F 1 contains six binding sites for nucleotides. Three of these are catalytic sites. The other three, for which a function has yet to be defined, are called non-catalytic sites.
In the crystal structure of the bovine heart mitochondrial F 1 -ATPase (MF 1 ) 1 deduced by Abrahams et al. (3) , the ␣ and ␤ subunits are arranged alternately in an (␣␤) 3 hexamer, the central cavity of which is occupied with a coiled-coil composed of the ␣-helical amino and carboxyl termini of the ␥ subunit. In the crystal structure of the bovine enzyme, non-catalytic sites are located at ␣/␤ interfaces and contain bound MgAMP-PNP. In contrast, the three catalytic sites, located at different ␣/␤ interfaces, are heterogeneously liganded. One, designated ␤ T , contains MgAMP-PNP; another, designated ␤ D , contains MgADP; and the third, designated ␤ E , is empty. In the crystal structure, ␣ subunits, which contain most of the amino acid side chains that interact with bound MgAMP-PNP, are in closed conformations. The conformations of ␤ T and ␤ D , which contain most of the amino acid side chains that interact with MgAMP-PNP and MgADP, respectively, are also closed and are very similar to the closed conformation of ␣ subunits. In contrast, ␤ E exists in an open conformation that is substantially different from the nearly common conformation of ␤ T and ␤ D . As pointed out earlier, the amino acid side chains that interact with bound Mg 2ϩ or the anionic oxygens of bound nucleotides in ␤ T and ␤ D in the crystal structure of MF 1 are rearranged to a great extent in the open conformation of ␤ E compared with the closed conformations of ␤ D and ␤ T (4) .
Substantial experimental evidence accumulated by Boyer (5, 6) before the crystal structure of MF 1 was determined suggested that the three catalytic sites of F 1 fire sequentially during ATP synthesis and hydrolysis. From these observations and asymmetry seen in early electron micrographs of F 1 -ATPases (7, 8) , it was predicted that the minor subunits (later shown for the Escherichia coli enzyme to include the ␥ and ⑀ subunits) rotate with respect to the hexameric arrangement of ␣ and ␤ subunits (5, 6) . Experiments designed on the basis of the crystal structure of MF 1 demonstrated that the ␥ subunit does indeed rotate in a counterclockwise direction when F 1 hydrolyzes ATP (9 -12) . Although several models have been proposed, a generally accepted, detailed mechanism for coupling ATP synthesis and hydrolysis to rotation of the ␥ subunit has not been described.
Until Weber et al. (13) reported that the ␤Y345W mutant 2 of Escherichia coli F 1 -ATPase (EF 1 ) does not catalyze ATP hydrolysis at significant rates until the third catalytic site of the enzyme binds ATP, the bisite binding change model of Boyer (6) was generally accepted as a working hypothesis for the molecular mechanism of ATP synthesis and hydrolysis catalyzed by F 0 F 1 . Subsequently, Weber et al. (14) proposed a trisite model for ATP hydrolysis that takes into account their findings with the ␤Y345W mutant of EF 1 and the different responses of the fluorescence emission spectrum of the ␤F155W mutant of EF 1 on binding MgAMP-PNP as opposed to binding MgADP to catalytic sites. From the latter analysis, it was concluded that, during steady-state ATP hydrolysis by the ␤F155W mutant, MgADP is bound to two catalytic sites, and MgATP is bound to a single catalytic site. However, this model predicts that the product P i is released from a catalytic site in one catalytic cycle, whereas the product ADP is released in the next catalytic cycle. Consequently, as Senior et al. (15) have pointed out, simply reversing the arrows in the four-step model does not provide a mechanism for ATP synthesis. This is in conflict with the intermediate H 2 O u P i oxygen exchange reaction observed when isolated F 1 -ATPases hydrolyze ATP, indicating that ATP synthesis and hydrolysis share a common transition state (16) .
Whether the fluorescence spectrum of the introduced tryptophans of the ␤F155W mutant of EF 1 accurately reports occupancy of catalytic sites with MgADP and ATP is also questionable for the following reasons. Weber and Senior (17) subsequently reported that the fluorescence spectrum of the introduced tryptophans indicated that MgATP is entrapped in three catalytic sites when the ATPase activity of the ␤F155W mutant of EF 1 is inhibited with azide. However, substantial evidence reported from several laboratories indicates that inhibition of ATPase activity by azide is turnover-dependent and entraps a stabilized form of inhibitory MgADP in a catalytic site (18 -21) . Furthermore, it is not obvious from inspection of the crystal structure of MF 1 why the fluorescence spectrum of the introduced tryptophans in the ␤F155W mutant should report occupancy of catalytic sites with MgADP and MgATP during steady-state ATP hydrolysis. Fig. 1 illustrates that, in the original crystal structure of MF 1 (3), the phenyl side chain of ␤Phe 155 in ␤ T points away from the ␥-phosphate of bound AMP-PNP. The phenyl side chain and amide nitrogen of ␤Phe 155 are 12.5 and 9 Å, respectively, from the nearest oxygen in the ␥-phosphate of bound AMP-PNP. In ␤ D , the phenyl side chain and amide nitrogen of ␤Phe 155 are separated from the nearest oxygen in the ␤-phosphate of bound ADP by about the same distances. In the original crystal structure of bovine F 1 , the closest neighbor of the phenyl ring of ␤Phe 155 is the phenyl ring of ␤Phe 326 in all three ␤ subunits. Whereas the C atoms in the phenyl rings are 3.5 Å apart and point toward each other in ␤ E , the rings are stacked in ␤ T and ␤ D , where they are 3.5 and 3.4 Å apart, respectively. The phenyl rings of these residues have similar orientations in ␤ T and ␤ D in the recently reported crystal structure of MF 1 containing MgADP-fluoroaluminate bound to two catalytic sites present in fully closed conformations and MgADP plus sulfate bound to the catalytic site (designated ␤ E ) that is in the half-closed conformation. In this crystal structure, the stacked phenyl rings in ␤ T and ␤ D are 3.7 and 3.8 Å apart, respectively, and the C atoms of the rings are end-to-end and 3.4 Å apart in the half-closed ␤ subunit containing MgADP and sulfate (22) .
The close proximity of the phenyl rings of ␤Phe 155 and ␤Phe 326 in the crystal structures of MF 1 suggests that the responses of the introduced tryptophans in the ␤F155W mutant of EF 1 induced by binding nucleotides to catalytic sites might reflect changes in the orientation of the indole of the introduced tryptophans at ␤Phe 155 with respect to the phenyl rings of ␤Phe 326 . To test this possibility, we have prepared the ␣ 3 ␤ 3 ␥ subcomplexes of thermophilic Bacillus PS3 F 1 -ATPase (TF 1 ) containing the ␤F155W and ␤F326W substitutions. The responses of the fluorescence emission spectrum of each mutant upon binding nucleoside di-and triphosphates to catalytic sites as well as the catalytic characteristics of the mutant enzymes have been examined in detail. The results and conclusions drawn from these experiments are reported here.
EXPERIMENTAL PROCEDURES
Materials-Enzymes, biochemicals used in assays, and ingredients of buffers were purchased from Sigma. Sodium azide was purchased from Aldrich; aluminum chloride was from Fisher; and lauryl dimethylamine oxide was from Calbiochem. The primers for generating the ␣ 3 (␤F155W) 3 ␥ and ␣ 3 (␤F326W) 3 ␥ mutant subcomplexes using the polymerase chain reaction were purchased from Invitrogen. Ecoscint from 2 National Diagnostics, Inc. was used to detect radioactivity with a Packard 1600 TR scintillation counter.
Generation and Expression of the ␣ 3 (␤F155W) 3 ␥ and ␣ 3 (␤F326W) 3 ␥ Mutant Subcomplexes of TF 1 -Plasmid pKK, which carries the genes encoding the ␣, ␤, and ␥ subunits of TF 1 , was used for mutagenesis and gene expression (23) . Mutant expression plasmids were prepared by the polymerase chain reaction using the QuikChange mutagenesis kit from Stratagene. The primers and their corresponding complements (not shown) that were used to incorporate the base changes for the ␤F155W and ␤F326W substitutions into pKK were as follows: 5Ј-GGC GGA AAA ATC GGT TTG TGG GGC GGC G-3Ј and 5Ј-GCT CCG GCC ACG ACG TGG TCG CAC TTG GAT GCG-3Ј, respectively. The base changes are underlined. The plasmid DNA was purified using the Wizard Plus miniprep system (Promega). After confirming the mutations by sequence analysis, the pKK mutant plasmids were expressed in JM103 (unc Ϫ ). Preparation of the Mutant and Wild-type Subcomplexes for Kinetic and Fluorescence Measurements-After expression, the wild-type and mutant ␣ 3 ␤ 3 ␥ subcomplexes were purified to homogeneity as described by Matsui and Yoshida (23) and were stored at 4°C as precipitates in 70% ammonium sulfate. Solutions of the subcomplexes used for kinetic and fluorescence measurements were freed of endogenous nucleotides by treatment with CDTA as described in detail previously (24) . The CDTA-treated preparations were shown to be free of ATP and contained Ͻ0.05 mol of ADP/mol of enzyme as determined by anion-exchange high pressure liquid chromatography on a TSK DEAE-5PW column. Protein concentrations were determined by the method of Bradford (25) .
Preparation of the ␣ 3 (␤F155W) 3 Fluorescence Measurements-The fluorescence emission spectra were recorded from 310 to 410 nm using a Spex Fluoromax-2 spectrofluorometer when the ␣ 3 (␤F155W) 3 ␥, ␣ 3 (␤F326W) 3 ␥, and ␣ 3 (␤Y345W) 3 ␥ subcomplexes at 50 nM were excited at 295 nm in 50 mM Tris-Cl (pH 8.0) containing the additions indicated in the figure legends. 3 ␥ and ␣ 3 (␤F326W) 3 ␥ Mutant Subcomplexes with Those of the Wild-type Subcomplex- Fig. 2 compares the effects of increasing Mg 2ϩ concentration on the rate of hydrolysis of 2 mM ATP by the mutant and wild-type enzymes. With the wild-type enzyme and the ␤F326W mutant, the maximal rates of hydrolysis were observed when the ATP/Mg 2ϩ ratios were ϳ1.8:1 and 2.0:1, respectively. In each of these cases, the rate of hydrolysis decreased significantly as the ATP/Mg 2ϩ ratio decreased below the optimal concentration, indicating that free Mg 2ϩ is inhibitory. In contrast, free Mg 2ϩ in the assay medium did not affect the rate of hydrolysis of 2 mM ATP by the ␤F155W mutant. The k cat values calculated for hydrolysis of 2 mM ATP at the optimal ATP/Mg 2ϩ ratio by the wild-type and ␤F155W and ␤F326W mutant enzymes are 245, 432, and 419 s Ϫ1 , respectively. As shown in Fig. 3 , hydrolysis of 2 mM ATP catalyzed by the two mutant enzymes was less sensitive to inhibition by azide than hydrolysis catalyzed by the wild-type enzyme. Whereas the wild-type subcomplex was inhibited by 80% in the presence of 100 M NaN 3 , the ␤F155W and ␤F326W mutants were inhibited by 20 and 45%, respectively, under the same conditions. The wild-type and mutant enzymes also responded differently to increasing concentrations of lauryl dimethylamine oxide in the assay medium during hydrolysis of 2 mM ATP.
RESULTS

Comparison of the Catalytic Properties of the ␣ 3 (␤F155W)
Whereas the wild-type enzyme was stimulated ϳ4-fold in the presence of 0.05-0.20% lauryl dimethylamine oxide, the ␤F326W mutant was stimulated by only 50%. In contrast, hydrolysis of 2 mM ATP by the ␤F155W mutant enzyme was inhibited by ϳ30% in the presence of 0.05-0.20% lauryl dimethylamine oxide in the assay medium.
The Fluorescence Emission Spectrum of the ␣ 3 (␤F155W) 3 (14) showed that the introduced tryptophans in the ␤F155W mutant of EF 1 fluoresced with an emission maximum at ϳ340 nm. They also showed that, in the presence of 2 mM MgADP, fluorescence was quenched and blue-shifted between 325 and 390 nm, with maximal quenching occurring at 350 nm. In contrast, they showed that, in the presence of 2 mM AMP-PNP, minor quenching was observed
␥ Subcomplex Does Not Respond in Regular Increments as the Number of Catalytic Sites Containing Bound Nucleotides Increases-Weber et al.
FIG. 2. Comparison of the effects of increasing Mg
2؉ concentration on the ATPase activity of the ␣ 3 ␤ 3 ␥, ␣ 3 (␤F155W) 3 ␥, and ␣ 3 (␤F326W) 3 ␥ subcomplexes. Samples of the subcomplexes (1.0 g each) were assayed at 30°C with 2 mM ATP in the presence of the indicated concentrations MgCl 2 with an ATP regeneration system. q, wild-type subcomplex; f, ␣ 3 (␤F155W) 3 ␥ subcomplex; OE, ␣ 3 (␤F326W) 3 ␥ subcomplex.
FIG. 3.
Comparison of the effects of increasing azide concentration on the ATPase activity of the ␣ 3 ␤ 3 ␥, ␣ 3 (␤F155W) 3 ␥, and ␣ 3 (␤F326W) 3 ␥ subcomplexes. Samples of the subcomplexes (1.0 g each) were assayed at 30°C with 2 mM ATP and 3 mM MgCl 2 in the presence of the indicated NaN 3 concentrations using an ATP regeneration system. q, wild-type subcomplex; f, ␣ 3 (␤F155W) 3 
between 350 and 390 nm, whereas fluorescence was enhanced and blue-shifted between 310 and 348 nm, with maximal enhancement occurring at 325 nm (see Fig. 3 of Ref. 14). When the EF 1 mutant was titrated with 0.1-2000 M MgADP, the biphasic fluorescence quenching observed at 350 nm fit a theoretical curve, suggesting that MgADP binding to a single catalytic site of higher affinity caused 50% quenching and that the remainder of the 12% quenching observed at saturation was caused by binding MgADP to the two catalytic sites of lower affinity. In contrast, when the mutant enzyme was titrated with 0.1-2000 M MgAMP-PNP, the fluorescence enhancement observed at 325 nm fit a theoretical curve, indicating a single catalytic site of higher affinity and two catalytic sites of lower affinity, with each site contributing equally to the 14% enhancement observed at saturation (see Fig. 4 of Ref. 14) . Fig. 4 shows that, in the absence of nucleotides, the fluorescence emission spectrum of the ␤F155W mutant subcomplex was very similar to that reported for the ␤F155W mutant of EF 1 . However, the fluorescence spectrum of the ␤F155W subcomplex of TF 1 responded differently upon binding MgADP or MgAMP-PNP to catalytic sites. Fig. 4A illustrates the shifts in the fluorescence emission spectrum accompanying addition of stoichiometric MgADP, on the one hand, and 2 mM MgADP, on the other, to the mutant enzyme. The emission maximum shifted from 343 to 337 nm when stoichiometric MgADP was added to the mutant enzyme. This was accompanied by 16% fluorescence quenching at 337 nm, the new emission maximum, and 19% quenching at 343 nm, the original emission maximum. A significant blue shift was also observed between 355 and 400 nm. Following addition of 2 mM MgADP to the ␤F155W mutant, the emission maximum also shifted from 343 to 337 nm. This was accompanied by significantly less quenching (9% at 337 nm and 13% at 343 nm) than observed after addition of stoichiometric MgADP. Essentially the same blue shift was observed between 355 and 400 nm when stoichiometric or 2 mM MgADP was added to the ␤F155W mutant. However, a significantly greater blue shift was observed between 315 and 330 nm following addition of 2 mM MgADP compared with that observed when stoichiometric MgADP was added. It is clear from the comparisons illustrated in Fig. 4A that the fluorescence spectrum of the introduced tryptophans in the ␤F155W mutant subcomplex did not respond in regular increments at any wavelength as the number of catalytic sites occupied with MgADP increased.
The responses of the fluorescence spectrum of the introduced tryptophans induced by addition of stoichiometric and 2 mM MgAMP-PNP to the ␤F155W mutant enzyme in separate experiments are illustrated in Fig. 4B . The shift in the emission spectrum accompanying addition of stoichiometric MgAMP-PNP was very similar to the shift observed when stoichiometric MgADP was added, as illustrated in Fig. 4A , except that addition of stoichiometric MgAMP-PNP induced slightly less quenching at 337 nm and a less pronounced blue shift between 355 and 400 nm. In contrast, the change in fluorescence accompanying addition of 2 mM MgAMP-PNP to the mutant enzyme shown in Fig. 4B differed considerably from the response accompanying addition of 2 mM MgADP illustrated in Fig. 4A . Following addition of 2 mM MgAMP-PNP, the emission maximum shifted from 343 to 328 nm. This was accompanied by substantially augmented fluorescence over that observed in the absence of nucleotides. Addition of stoichiometric MgAMP-PNP to the mutant enzyme had essentially no effect on fluorescence emission at 328 nm, whereas following addition of 2 mM MgAMP-PNP to the mutant enzyme, fluorescence emission at this wavelength increased by 42%. As observed when MgADP bound to catalytic sites of the ␤F155W mutant, the fluorescence spectrum of the introduced tryptophans in the mutant enzyme did not respond in regular increments at any wavelength as the number of catalytic sites occupied with MgAMP-PNP increased. illustrates that the shift in the fluorescence emission spectrum following addition of 2 mM ADP to the mutant enzyme in the absence of Mg 2ϩ was very similar to the shift observed when 2 mM ADP was added in the presence of Mg 2ϩ , as shown in Fig.  4A . The shift in the emission spectrum of the ␤F155W mutant enzyme observed when stoichiometric or 2 mM ATP was added is illustrated in Fig. 4D . Addition of stoichiometric ATP caused minor fluorescence quenching between 330 and 340 nm. The shift in the fluorescence emission spectrum observed after adding 2 mM ATP to the mutant enzyme qualitatively resembled the shift observed following addition of 2 mM AMP-PNP in the presence of Mg 2ϩ (Fig. 4B ) in that similar blue shifts were generated. However, the increase in fluorescence at 330 nm over that observed in the control not containing nucleotides was ϳ2-fold greater in the case of 2 mM AMP-PNP in the presence of Mg 2ϩ . Fig. 5 illustrates the fluorescence spectra observed after forming MgADP-fluoroaluminate complexes in one or two catalytic sites of the ␤F155W mutant enzyme. Comparison of the spectra illustrated in Figs. 4A and 5 shows that conversion of MgADP bound to a single catalytic site (Fig. 4A, dashed curve) of the ␤F155W mutant enzyme to the MgADP-fluoroaluminate complex (Fig. 5, dotted curve) was accompanied by a small increase in fluorescence at the emission maximum (337 nm) and a significant red shift between ϳ355 and 390 nm. In contrast, conversion of Mg [ 3 H]ADP bound to multiple catalytic sites of the ␤F155W mutant enzyme (Fig. 4A, dotted (Fig. 5 , dashed curve) as described under "Experimental Procedures" generated a fluorescence spectrum qualitatively similar to the spectrum illustrated in Fig. 4B (dotted curve) that was generated after addition of 2 mM MgAMP-PNP to the mutant enzyme. The fluorescence at the 328 nm emission maximum observed after adding 2 mM MgAMP-PNP to the mutant enzyme (Fig. 4B, dotted curve) was ϳ15% greater than the fluorescence emission exhibited at the same wavelength after converting MgADP bound at two catalytic sites to Mg[ 3 H]ADPfluoroaluminate complexes (Fig. 5, dashed curve) . Essentially the same emission spectrum (data not shown; illustrated in Fig. 5, dashed curve) (27) . Therefore, it is reasonable to assume that only two catalytic sites contribute to the fluorescence spectrum induced when MgADP-fluoroaluminate complexes are formed in two catalytic sites when the mutant enzyme is treated with Al 3ϩ and F Ϫ in the presence of 200 M MgADP, whereas the third catalytic site containing MgADP does not contribute.
Comparison of the Responses of Fluorescence Spectra of the ␣ 3 (␤Y345W) 3 ␥ and ␣ 3 (␤F326W) 3 ␥ Mutant Subcomplexes following Addition of Stoichiometric and 2 mM Nucleotides in the Presence of Mg
2ϩ -When irradiated at 295 nm, the ␣ 3 (␤Y345W) 3 ␥ mutant subcomplex fluoresces with an emission maximum at 353 nm (28) . Fig. 6A illustrates that the emission spectrum of the introduced tryptophans in the ␤Y345W mutant subcomplex was quenched in nearly identical increments as its three catalytic sites were filled with nucleotides. Following addition of stoichiometric MgAMP-PNP, fluorescence at the emission maximum decreased by ϳ30%, whereas addition of 2 mM MgAMP-PNP led to complete quenching of the fluorescence of the introduced tryptophans. When two catalytic sites of the ␤Y345W mutant subcomplex were loaded with the MgADPfluoroaluminate complex (Fig. 6A , dash/dot curve) as described under "Experimental Procedures", ϳ68% of the fluorescence of the introduced tryptophans was quenched. Fig. 6B shows that the introduced tryptophans in the ␤F326W mutant subcomplex fluoresced with an emission maximum at 346 nm when irradiated at 295 nm. Fluorescence emission was not quenched in linear increments as the number of catalytic sites occupied with nucleotides increased. About 9% quenching of fluorescence was observed at the emission maximum following addition of stoichiometric MgAMP-PNP, whereas addition of 2 mM MgAMP-PNP, which should saturate all three catalytic sites, quenched 20% of the fluorescence at the emission maximum. Similar behavior was observed when the ␤F326W mutant was treated with stoichiometric and 2 mM MgADP. 3 ␥ Subcomplex-The wild-type ␣ 3 ␤ 3 ␥ subcomplex of TF 1 contains three tryptophan residues located at residue 463 in ␣ subunits that do not fluoresce when the wild-type enzyme is irradiated at 295 nm in the absence of denaturants (28) . However, in buffer containing 8 M guanidine HCl, the wild-type enzyme exhibited a typical tryptophan fluorescence spectrum with an emission maximum at 355 nm when irradiated at 295 nm (data not shown). observed upon denaturation was contributed by the endogenous and introduced tryptophans. Comparison of the emission spectra observed in the presence and absence of guanidine HCl clearly shows that a substantial red shift in the spectrum of the introduced tryptophans accompanied denaturation of the ␤F155W mutant subcomplex.
The Red Shift Observed in the Fluorescence Emission Spectrum of the Introduced Tryptophans upon Denaturation of the ␣ 3 (␤F155W)
DISCUSSION
Comparison of the catalytic properties of the ␣ 3 (␤F155W) 3 ␥ and ␣ 3 (␤F326W) 3 ␥ mutant subcomplexes with those of the wildtype ␣ 3 ␤ 3 ␥ subcomplex of TF 1 revealed that the ␤F155W substitution substantially decreases the propensity of the enzyme to entrap inhibitory MgADP in a catalytic site during turnover compared with the wild-type enzyme. In contrast, the catalytic properties of the ␤F326W mutant enzyme deviate from those of the wild-type enzyme to a lesser extent. This comparison suggests that substitution of Phe with Trp at position ␤155 distorts the structure of the ␤ subunit more than substitution of Phe with Trp at position ␤326. The different responses of the fluorescence emission spectra of the introduced tryptophans in the two mutants are consistent with this contention.
In the absence of nucleotides, the emission maximum of the introduced tryptophans exhibited by the ␤F155W mutant subcomplex was significantly blue-shifted compared with the emission maximum observed after denaturing them with guanidine HCl. Similar characteristics were exhibited by the ␤F326W mutant subcomplex (data not shown). However, the fluorescence spectra of the two mutant enzymes responded differently as catalytic sites were filled with nucleotides. In the case of the ␤F326W mutant, fluorescence quenching occurred without a significant shift in the emission maximum as catalytic sites were filled with nucleotides. This quenching is consistent with the stacked arrangement of the phenyl side chains of ␤Phe 155 and ␤Phe 326 in ␤ T in the crystal structure of MF 1 illustrated in Fig. 1 . The side chains of these residues are also stacked and are 3.5 Å apart in ␤ D . In contrast, Fig. 1 illustrates that the phenyl side chains of these residues are arranged end-to-end in ␤ E . To explain the molecular basis of the quenching observed, it is inferred from the crystal structure of MF 1 that binding nucleotides to catalytic sites in the ␣ 3 (␤F326W) 3 ␥ subcomplex induces rearrangement of the side chain of the introduced tryptophans at position 326 and the phenylalanine side chains at position ␤155 in a manner that promotes enhancedinteractions in ␤ T and ␤ D .
In contrast, the pronounced blue shifts induced when nucleotides bind to catalytic sites of the ␤F155W mutant are not amenable to a similar interpretation. However, a study recently reported by Nanda and Brand (29) provides clues for interpreting the blue shifts observed when nucleotides bind to catalytic sites of the ␣ 3 (␤F155W) 3 ␥ subcomplex. From appropriate models, Nanda and Brand suggest that the unusually low quantum yield of fluorescence emission exhibited by Trp 48 in the Engrailed homeodomain of Drosophila is caused by an indole NH-hydrogen bond between the side chains of Trp 48 and Phe 8 in the excited state. Denaturation of the homeodomain in guanidine HCl led to a pronounced red shift of the emission maximum that was accompanied by a large increase in emission. Whereas denaturation of the ␣ 3 (␤F155W) 3 ␥ subcomplex in guanidine HCl led to a substantial red shift of the emission maximum of the introduced tryptophans, blue shifts were observed upon binding nucleotides to catalytic sites of the FIG. 6 . Responses of the fluorescence emission spectra of the ␣ 3 (␤Y345W) 3 ␥ and ␣ 3 (␤F326W) 3 ␥ subcomplexes upon addition of nucleotides in the presence of Mg 2؉ . A, the fluorescence emission spectra observed upon exciting 50 nM ␣ 3 (␤Y345W) 3 ␥ in 50 mM Tris-Cl (pH 8.0) at 295 nm with the following additions: no addition (solid curve), 50 nM AMP-PNP and 1 mM MgCl 2 (dashed curve), the MgADPfluoroaluminate complexes bound to two catalytic sites formed as described for ␣ 3 (␤F155W) 3 ␥ under "Experimental Procedures" (dash/dot curve), and 2 mM AMP-PNP and 3 mM MgCl 2 (dotted curve). B, the fluorescence emission spectra observed upon exciting 50 nM ␣ 3 (␤F326W) 3 ␥ in 50 mM Tris-Cl (pH 8.0) at 295 nm with the following additions: no addition (solid curve), 50 nM AMP-PNP and 1 mM MgCl 2 (dashed curve), and 2 mM AMP-PNP and 3 mM MgCl 2 (dotted curve).
FIG. 7. Effects of 8 M guanidine
HCl on the fluorescence emission spectra of the wild-type, ␣ 3 (␤F155W) 3 ␥, and ␣ 3 (␤F326W) 3 ␥ subcomplexes. Shown are the fluorescence emission spectra of 50 nM ␣ 3 (␤F155W) 3 ␥ in the presence and absence of 8 M guanidine HCl: the spectrum in 50 mM Tris-Cl (pH 8.0) (solid curve) and the spectrum determined at 25°C after adding ␣ 3 (␤F155W) 3 ␥ to 50 mM Tris-Cl (pH 8.0) containing 8 M guanidine HCl (dotted curve). mutant enzyme. Therefore, it is possible that reorientation of the indole NH of ␤Trp 155 with respect to the phenyl ring of ␤Phe 326 is responsible for the responses of the fluorescence emission spectrum observed as catalytic sites of the ␣ 3 (␤F155W) 3 ␥ subcomplex are filled with nucleotides. Comparison of the catalytic properties of the ␤F155W mutant enzyme with those of the wild-type enzyme illustrated in Figs. 2 and 3 suggests that the amino acid substitution of the phenylalanine immediately preceding the P-loop with tryptophan abolishes sensitivity to excess Mg 2ϩ ion in the assay medium and substantially reduces sensitivity to inhibition by azide. Therefore, it is not unreasonable to assume that occupancy of catalytic sites with different ligands might differently affect the orientation of the side chain of the introduced tryptophan with the side chain of ␤Phe 326 . The finding that [ 3 H]ADP was entrapped in only two catalytic sites when the ␤F155W and ␤Y345W mutants were treated with 2 mM Mg[ 3 H]ADP followed by Al 3ϩ and F Ϫ is consistent with earlier observations indicating that three ␤ subunits cannot simultaneously exist in closed conformations (30, 31) . For instance, Fig. 1 illustrates that the guanidinium side chain of ␤Arg 337 is within 3.0 Å of the carboxylate of ␤Asp 315 in ␤ T , whereas these groups are Ͼ10 Å apart in ␤ E in the crystal structure of MF 1 . The guanidinium and carboxylate of these residues are within 3.7 Å of each other in ␤ D in the crystal structure. Although disulfide bonds formed readily between the introduced cysteines in two ␤ subunits when the ␣ 3 (␤D315C/R337C) 3 ␥ double mutant was treated with oxidants in the presence or absence of bound nucleotides, it was not possible to cross-link the introduced cysteines in the third ␤ subunit even when catalytic sites were saturated with MgADP (31). The emission spectrum observed when MgADP-fluoroaluminate complexes were bound to two catalytic sites of the ␤F155W mutant was intermediate between the spectra observed when the enzyme was treated with 2 mM MgATP in the presence or absence of azide (data not shown), on the one hand, and MgAMP-PNP, on the other. Therefore, filling only two catalytic sites with nucleotides is sufficient to induce the interactions between the indole side chain of the introduced tryptophan at position ␤155 with the phenylalanine side chain at position ␤326 that cause the maximal shifts in the fluorescence emission spectrum that were observed.
The responses of the fluorescence spectrum of the introduced tryptophans after adding stoichiometric or 2 mM nucleotides to the ␣ 3 (␤F155W) 3 ␥ subcomplex of TF 1 described here differ considerably from the responses of the introduced tryptophans observed when catalytic sites of the corresponding mutant of EF 1 are filled with nucleotides (14) . The results presented for the ␤F155W mutant of TF 1 clearly show that, unlike the ␣ 3 (␤Y345W) 3 ␥ subcomplex, there is no direct relationship between the changes in fluorescence spectrum of the introduced tryptophans and the number of catalytic sites occupied with nucleotides. Addition of stoichiometric MgADP or MgAMP-PNP to the ␣ 3 (␤F155W) 3 ␥ subcomplex of TF 1 led to very similar fluorescence spectra that were attenuated and blue-shifted in the region between 330 and 400 nm. Although addition of 2 mM MgADP to the ␤F157W mutant generated a fluorescence spectrum that differed considerably from the spectrum observed after adding 2 mM MgAMP-PNP to the enzyme, in each case, the fluorescence was enhanced in the region between 310 and 355 nm over that observed when stoichiometric MgADP or MgAMP-PNP was added. In contrast, Weber et al. (14) reported that only quenching of fluorescence was observed at 350 nm when the ␤F155W mutant of EF 1 One or more of the following possibilities may be responsible for the difference in the responses of the introduced tryptophans upon addition of nucleotides to the ␤F155W mutant of TF 1 and the corresponding mutant of EF 1 . 1) The ␣ 3 (␤F155W) 3 ␥ subcomplex was used in this study, whereas the EF 1 mutant enzyme contains five subunits. 2) Only a single amino acid substitution is present in the ␣ 3 (␤F155W) 3 ␥ subcomplex of TF 1 , whereas the ␤F155W mutant of EF 1 contains five additional substitutions that were necessary to remove endogenous tryptophans. 3) Because the amino acid sequences of the ␣, ␤, and ␥ subunits of TF 1 and EF 1 are similar, but not identical, it is possible that these differences, especially those in ␤ subunits, might be responsible for the different responses of the fluorescence emission spectra of the two mutant enzymes upon binding nucleotides to catalytic sites. 4) Whereas titrations of the tryptophan fluorescence of the ␣ 3 (␤F155W) 3 ␥ subcomplex reported here were conducted with enzyme completely free of endogenous nucleotides, this was not the case with the ␤F155W mutant used by Weber et al. (14) .
Although possibilities 1-3 cannot be excluded completely, there is evidence suggesting that they may not be important factors for the differences observed. It has been shown that removal of the ⑀ subunit from the ␤F345W mutant of EF 1 decreases the affinity of catalytic site 1 for MgADP and MgATP, whereas the affinities of catalytic sites 2 and 3 are unaffected (33) . Because addition of stoichiometric MgAMP-PNP to the ␣ 3 (␤F345W) 3 ␥ subcomplex of TF 1 quenches fluorescence emission by one-third, the lower affinity of the first catalytic site loaded in the absence of the ⑀ subunit in the TF 1 subcomplex does not appear to be responsible for the differences observed. Substitution of all tryptophan residues in wild-type EF 1 increases V max and K m ϳ2-fold (34), indicating that these substitutions are not likely to be responsible for the different fluorescence responses observed with the two ␤F155W mutant enzymes. In F 1 -ATPases, ␤Phe 155 immediately precedes the P-loop (the consensus sequence ␤156 GGAGVGKT 163 ), which contains amino acid residues that interact directly with either the Mg 2ϩ ion or anionic oxygens in Mg 2ϩ complexes of nucleotides bound to catalytic sites in crystal structures of MF 1 (3, 22) . The catalytic characteristics of the ␤T163S mutant of yeast F 1 described by Mueller (35) and those of the ␤T163S mutant subcomplex of TF 1 (24) are very similar in that both have ϳ3-fold greater specific activity and are much less sensitive to inhibition by azide than the corresponding wild-type enzymes. This indicates that single amino acid substitutions in the P-loop region of F 1 -ATPases might not be greatly influenced by differences in primary structure.
However, there is evidence that differences in the content of endogenous nucleotides in the mutant enzymes may be responsible for the discrepancies. The ␣ 3 (␤F155W) 3 ␥ subcomplex used in this study is essentially free of endogenous nucleotides. In contrast, the ␤F155W mutant of EF 1 employed by Weber et al. (14) probably contains nucleotides bound to non-catalytic sites. Before analysis, it was passed consecutively through two centrifuge columns of Sephadex G-50 to remove endogenous nucleotides from catalytic sites. However, it was subsequently reported that wild-type EF 1 prepared in this manner was inactivated by Ͼ50% when treated with Mg 2ϩ , ScCl 3 , and NaF, indicating formation of the MgADP-fluoroscandinate complex in a catalytic site in the absence of added ADP (32) . From this observation, it was proposed that, under the conditions of the experiment, the MgADP-fluoroscandinate complex arose from ADP that had dissociated from non-catalytic sites. The same behavior should apply to the ␤F155W mutant of EF 1 .
Given these ambiguities, the nucleotide content of catalytic sites during steady-state ATP hydrolysis remains an open question. Therefore, the model proposed in Refs. 27, 36, and 37 that describes minimal schemes for single rounds of ATP hydrolysis and ATP synthesis coupled to rotation of the ␥ subunit of F 1 remains plausible. Three important features that distinguish the trisite model proposed for ATP hydrolysis (27, 36, 37) from the trisite model proposed by Weber et al. (14) are as follows: 1) three catalytic sites cannot assume completely closed conformations simultaneously; 2) the transition state for ATP hydrolysis forms as a catalytic site containing MgATP converts from the fully closed conformation to the fully open conformation, from which both products are released simultaneously; and 3) simply reversing the arrows provides a mechanism for ATP synthesis. According to the reciprocal model proposed for ATP synthesis (27, 36) , the transition state forms when an open catalytic site containing bound MgADP and P i converts to a closed conformation containing bound MgATP driven by energy-dependent clockwise rotation of the ␥ subunit.
The proposed reciprocal models are entirely consistent with observations that have led others to suggest that ATP synthesis catalyzed by ATP synthase is not the reverse of ATP hydrolysis (38 -41) . Penefsky (38) showed that AMP-PNP bound to catalytic sites of MF 1 in submitochondrial particles severely inhibited ATP hydrolysis, but had no effect on ATP synthesis driven by NADH or succinate. Similar observations were reported by Minkov et al. (39) , who showed that MgADP bound to catalytic sites of F 1 in submitochondrial particles inhibited ATP hydrolysis, but had no effect on ATP synthesis. In a more comprehensive study, Du and Boyer (42) 
